earnings
confidence high
sentiment positive
materiality 0.75
Surgery Partners Q3 revenue $770.4M (+14.3% YoY); adjusted EBITDA $128.6M (+21.9%)
Surgery Partners, Inc.
2024-Q3 EPS reported
-$0.47
revenue$2,249,900,000
- Revenue $770.4M, +14.3% YoY; same-facility revenue +4.2% on 3.7% case growth.
- Adjusted EBITDA $128.6M, +21.9% YoY; margin 16.7%, expanding 100 bps.
- Net loss attributable to Surgery Partners was $31.7M.
- FY 2024 outlook reaffirmed: revenue >$3.075B, adjusted EBITDA >$508M.
- Cash $221.8M, revolver capacity $595.8M; total net debt/EBITDA 3.8x.